Chemical context
Acridine derivatives occupy an important position in medicinal chemistry due to their wide range of biological applications. They exhibit fungicidal (Misra & Bahel, 1984; Srivastava et al., 1985) , anti-cancer (Sondhi et al., 2004; Sugaya et al., 1994; Kimura et al., 1993) , anti-parasitic (Ngadi et al., 1993) , antiinflammatory and anti-microbial (Shul'ga et al., 1974; Gaiukevich et al., 1973) activity. They are also components of effective analgesics (Taraporewala & Kauffman, 1990; Gaidukevich et al., 1987) . Other pharmaceutically active acridine derivatives (e.g. Mepacrine, Azacrine, Proflavine, and Aminacrine) also demonstrate antimalarial and antibacterial activity (Denny et al., 1983) .
Structural commentary
The structure of (1) is shown in Fig. 1 . The 3,3,6,6-tetramethyltetrahydroacridine-1,8-dione ring system is substituted at the central methine C9 atom by a 3-bromo-5-chloro-2-hydroxyphenyl ring and carries a hydroxyethyl substituent on the acridine N atom. The acridinedione ring system deviates significantly from planarity with an r.m.s. deviation of 0.336 Å for the 13 C atoms and one N atom of the acridine unit. This plane is almost orthogonal to the benzene ring plane [dihedral angle = 89.84 (6) ], a conformation that is stabilized by a strong intramolecular O92-H92Á Á ÁO8 hydrogen bond between the two systems (Table 1 ). Both the 3-bromo-5-chloro-2-hydroxyphenyl and hydroxyethyl substituents point in the same direction with respect to the acridine plane. Furthermore, one methyl group is axial and the other equatorial with respect to the two outer cyclohexenone rings of the acridinedione and again, the axial methyl substituents are found on the same face of the acridinedione ring system. Overall this ring system is V-shaped with the substituents mentioned above on the convex surface of the shallow V. The outer cyclohexenone rings both adopt flattened chair configurations with the C3 and C6 atoms each 0.646 (4) Å , in the same direction, from the best-fit planes through the remaining five C atoms. In contrast, the central C9/N10/C11-C14 ring can best be described as a flattened boat with C9 and N10 0.423 (4) and 0.154 (4) Å , respectively, from the best-fit plane through the remaining four C atoms. The bond lengths and angles in the molecule of (1) agree reasonably well with those found in closely related molecules .
Supramolecular features
The crystal structure of (1) features O102-H102Á Á ÁO1 hydrogen bonds, which link the molecules into zigzag chains parallel to the b axis (Fig. 2) . Weak C4-H4AÁ Á ÁCl95 together with C5-H5BÁ Á ÁO92 and C7-H7AÁ Á ÁO92 hydrogen bonds to the same acceptor oxygen atom form R The structure of (1) with ellipsoids drawn at the 50% probability level.
Figure 2
Zigzag chains of (1) parallel to the b axis with hydrogen bonds drawn as dashed lines and symmetry operations shown in Table 1 . For clarity, H atoms bound to atoms not involved in hydrogen bonding are not shown. Table 1 Hydrogen-bond geometry (Å , ). 
Figure 3
Sheets of molecules of (1) parallel to (421) with hydrogen bonds drawn as dashed lines and symmetry operations shown in Table 1 . For clarity, H atoms bound to atoms not involved in hydrogen bonding are not shown. (Fig. 4) . Overall, these interactions stack the molecules into interconnected columns along the a-axis direction (Fig. 5 ).
Database survey
Numerous structures of acridine and its derivatives have been reported previously, with 373 entries in the current database (Version 5.35, November 2013 with 1 update; Allen, 2002) . However, far fewer structures of derivatives of the seminal hydroacridine, 3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (Natarajan & Mathews, 2011) are found with only 25 unique structures of derivatives with an aryl substituent on the methine C atom and an alkyl or aryl substituent on the N atom. Of these, aromatic substituents on the N atom predominate with 15 entries (see, for example, Nakhi et al. 2013; Shi et al. 2008; Wang et al. 2003) . Two structures, 10-(2-hydroxyethyl)-9-(2-hydroxyphenyl)-3, 3,6,6-tetramethyl-1,2,3,4,5,6,7,8,9,10-decahydroacridine-1,8-dione (Abdelhamid et al., 2011) and 9-(5-bromo-2-hydroxyphenyl)-10-(2-hydroxypropyl)-3, 3,6,6-tetramethyl-1,2,3,4,5,6,7,8,9,10-decahydroacridine-1,8-dione (Khalilov et al., 2011) closely resemble (1), each with 2-hydroxy substituents on the aromatic rings that form intramolecular hydrogen bonds to one of the two keto O atoms in each molecule. In the first instance, the 2-hydroxyethyl substituent on the N atom is identical to that for (1), while the 2-hydroxypropyl substituent in the second analogue is closely related.
Synthesis and crystallization
A mixture of 1 mmol (235.5 mg) 3-bromo-5-chloro-2-hydroxybenzaldehyde, 2 mmol (280 mg) 5,5-dimethylcyclohexane-1,3-dione and 1 mmol (61 mg) amino-ethanol in 30 ml of ethanol was refluxed for 12 h. The reaction was monitored by TLC until completion. Excess solvent was evaporated under vacuum and the resulting solid product was recrystallized from a mixture of ethanol/acetone (10:1 v:v) to afford yellow needles of the title compound. M.p. 513 K, 82% yield. Chains of molecules of (1) along the diagonal of the ac plane with hydrogen bonds drawn as dashed lines and symmetry operations shown in Table 1 . For clarity, H atoms bound to atoms not involved in hydrogen bonding are not shown.
Figure 5
Overall packing for (1) viewed along the a axis with hydrogen bonds drawn as dashed lines. 
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . The H atoms of the two hydroxy substituents were located in an electron density map and their coordinates were freely refined with U iso = 1.5U eq (O). All H atoms bound to carbon were refined using a riding model with d(C-H) = 0.95 Å U iso = 1.2U eq (C) for aromatic, 0.99 Å , U iso = 1.2U eq (C) for methylene, 1.00 Å , U iso = 1.2U eq (C) for methine, and 0.98 Å , U iso = 1.5U eq (C) for methyl H atoms. 9-(3-bromo-5-chloro-2-hydroxyphenyl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H) (Agilent, 2013 ); cell refinement: CrysAlis PRO (Agilent, 2013) ; data reduction: CrysAlis PRO (Agilent, 2013); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) and TITAN2000 (Hunter & Simpson, 1999 ); program(s) used to refine structure: SHELXL2013 (Sheldrick, 2008) and TITAN2000 (Hunter & Simpson, 1999) ; molecular graphics: Mercury (Macrae et al., 2008) ; software used to prepare material for publication:
SHELXL2013 (Sheldrick, 2008) , enCIFer (Allen et al., 2004) , PLATON (Spek, 2009 ) and publCIF (Westrip, 2010) . 
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